Critical appraisal on the utility of echocardiography in the management of acute pulmonary embolism

Cardiology in Review

Volumn 18, Issue 1, 2010, Pages 29-37

  Mookadam, Farouk ^a   Jiamsripong, Panupong ^a   Goel, Ramil ^a   Warsame, Tahlil A ^a   Emani, Usha R ^a   Khandheria, Bijoy K ^a  

^a MAYO CLINIC   (United States)

Author keywords

Echocardiography; Pulmonary embolism; Right ventricular dysfunction; Risk stratification; Transesophageal echocardiography

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; WARFARIN;

BLOOD CLOT LYSIS; ECHOCARDIOGRAPHY; EMBOLECTOMY; EMERGENCY WARD; HEMODYNAMICS; HUMAN; HYPOKINESIA; INTRACARDIAC THROMBOSIS; LUNG ARTERY PRESSURE; LUNG EMBOLISM; MORBIDITY; MORTALITY; PATENT FORAMEN OVALE; PATIENT ASSESSMENT; PERSISTENT PULMONARY HYPERTENSION; PROGNOSIS; REVIEW; RISK ASSESSMENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT RESPONSE;

ACUTE DISEASE; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HUMANS; PROGNOSIS; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY;

EID: 74549181579     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3181c09443     Document Type: Review

References (82)

1. Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008;358:1037-1052.
2. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003;163:1711-1717.
3. Elliott CG: Pulmonary physiology during pulmonary embolism. Chest. 1992,101:163S-171S.
4. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost. 2001;86:452-463.
5. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326:1240-1245.
6. Alpert JS, Smith R, Carlson J, et al. Mortality in patients treated for pulmonary embolism. JAMA. 1976;236:1477-1480.
7. Coon WW, Willis PW. Deep venous thrombosis and pulmonary embolism: prediction, prevention and treatment. Am J Cardiol. 1959;4:611-621.
8. Soloff LA, Rodman T. Acute pulmonary embolism. II. Clinical. Am Heart J. 1967;74:829-847.
9. Quiroz R, Kucher N, Zou KH, et al. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA. 2005;293:2012-2017.
10. Piazza G, Goldhaber SZ. Acute pulmonary embolism: part I: epidemiology and diagnosis. Circulation. 2006;114:e28-e32. (Pubitemid 44420733)
11. Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Intern Med. 2002;136:691-700.
12. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA. 1990,263:2753-2759.
13. Elliott CG, Goldhaber SZ, Jensen RL. Delays in diagnosis of deep vein thrombosis and pulmonary embolism. Chest. 2005;128:3372-3376.
14. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386-1389.
15. Konstantinides S, Geibel A, Olschewski M, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation. 1997;96:882-888.
16. Come PC: Echocardiographic evaluation of pulmonary embolism and its response to therapeutic interventions. Chest. 1992,101:151S-162S.
17. Kucher N, Rossi E, De Rosa M, et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med. 2005;165:1777-1781.
18. Gibson NS, Sohne M, Buller HR. Prognostic value of echocardiography and spiral computed tomography in patients with pulmonary embolism. Curr Opin Pulm Med. 2005;11:380-384.
19. Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000;101:2817-2822.
20. Torbicki A, Galie N, Covezzoli A, et al. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol. 2003;41:2245-2251.
21. McConnell MV, Solomon SD, Rayan ME, et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol. 1996;78:469-473.
22. Jardin F, Dubourg O, Bourdarias JP. Echocardiographic pattern of acute cor pulmonale. Chest. 1997;111:209-217.
23. Ribeiro A, Juhlin-Dannfelt A, Brodin LA, et al. Pulmonary embolism: relation between the degree of right ventricle overload and the extent of perfusion defects. Am Heart J. 1998;135:868-874.
24. Kasper W, Geibel A, Tiede N, et al. Distinguishing between acute and subacute massive pulmonary embolism by conventional and Doppler echocardiography. Br Heart J. 1993;70:352-356.
25. Casazza F, Bongarzoni A, Capozi A, et al. Regional right ventricular dysfunction in acute pulmonary embolism and right ventricular infarction. Eur J Echocardiogr. 2005;6:11-14.
26. Kurzyna M, Torbicki A, Pruszczyk P, et al. Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. Am J Cardiol. 2002;90:507-511.
27. Furuno Y, Nagamoto Y, Fujita M, et al. Reflection as a cause of mid-systolic deceleration of pulmonary flow wave in dogs with acute pulmonary hypertension: comparison of pulmonary artery constriction with pulmonary embolisation. Cardiovasc Res. 1991;25:118-124.
28. Ferrari E, Imbert A, Chevalier T, et al. The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads-80 case reports. Chest. 1997;111:537-543.
29. Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation. 2005;112:e28-e32.
30. ten Wolde M, Sohne M, Quak E, et al. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med. 2004;164:1685-1689.
31. Kasper W, Konstantinides S, Geibel A, et al. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart. 1997;77:346-349.
32. Ogren M, Bergqvist D, Eriksson H, et al. Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies. Eur Heart J. 2005;26:1108-1114.
33. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normal and dilated cardiomyopathy. J Cardiol. 1995;26:357-366.
34. Park JH, Park YS, Park SJ, et al. Midventricular peak systolic strain and Tei index of the right ventricle correlated with decreased right ventricular systolic function in patients with acute pulmonary thromboembolism. Int J Cardiol. 2008;125:319-324.
35. Hsiao SH, Yang SH, Wang WC, et al. Usefulness of regional myocardial performance index to diagnose pulmonary embolism in patients with echocardiographic signs of pulmonary hypertension. Am J Cardiol. 2006;98: 1652-1655.
36. Lopez-Candales A, Dohi K, Bazaz R, et al. Relation of right ventricular free wall mechanical delay to right ventricular dysfunction as determined by tissue Doppler imaging. Am J Cardiol. 2005;96:602-606.
37. Rajdev S, Nanda NC, Patel V, et al. Tissue Doppler assessment of longitudinal right and left ventricular strain and strain rate in pulmonary artery hypertension. Echocardiography. 2006;23:872-879.
38. Lopez-Candales A, Rajagopalan N, Dohi K, et al. Abnormal right ventricular myocardial strain generation in mild pulmonary hypertension. Echocardiography. 2007;24:615-622.
39. Kittipovanonth M, Bellavia D, Chandrasekaran K, et al. Doppler myocardial imaging for early detection of right ventricular dysfunction in patients with pulmonary hypertension. J Am Soc Echocardiogr. 2008;21:1035-1041.
40. Rahimtoola A, Bergin JD. Acute pulmonary embolism: an update on diagnosis and management. Curr Probl Cardiol. 2005;30:61-114.
41. Weyman AE, Dillon JC, Feigenbaum H, et al. Echocardiographic patterns of pulmonic valve motion with pulmonary hypertension. Circulation. 1974;50: 905-910.
42. Nanda NC, Gramiak R, Robinson TI, et al. Echocardiographic evaluation of pulmonary hypertension. Circulation. 1974;50:575-581.
43. Kucher N, Goldhaber SZ. Risk stratification of acute pulmonary embolism. Semin Thromb Hemost. 2006;32:838-847.
44. Oh JK, Seward JB, Tajik AJ: Pulmonary hypertension and pulmonary vein stenosis. In: Oh JK ed. The Echo Manual. Philadelphia, PA: Lippincott William & Wilkins; 2007:143-153.
45. Dabestani A, Mahan G, Gardin JM, et al. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol. 1987;59:662-668.
46. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol. 1990;66:493-496.
47. Selimovic N, Rundqvist B, Bergh CH, et al. Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. J Heart Lung Transplant. 2007;26:927-934.
48. Rajagopalan N, Simon MA, Suffoletto MS, et al. Noninvasive estimation of pulmonary vascular resistance in pulmonary hypertension. Echocardiography. 2008;26:489-494.
49. Abbas AE, Fortuin FD, Schiller NB, et al. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol. 2003;41: 1021-1027.
50. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part II: risk stratification, treatment, and prevention. Circulation. 2003;108:2834-2838.
51. Konstantinides S, Geibel A, Kasper W, et al. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation. 1998;97:1946-1951.
52. Ribeiro A, Lindmarker P, Johnsson H, et al. Pulmonary embolism: one-year follow-up with echocardiography Doppler and five-year survival analysis. Circulation. 1999;99:1325-1330.
53. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008;29:2276-2315.
54. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation. 2003;107:2545-2547.
55. Pieralli F, Olivotto I, Vanni S, et al. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol. 2006; 97:1386-1390.
56. Coma-Canella I, Gamallo C, Martinez Onsurbe P, et al. Acute right ventricular infarction secondary to massive pulmonary embolism. Eur Heart J. 1988;9:534-540.
57. Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J. 2005;26:2166-2172.
58. Scridon T, Scridon C, Skali H, et al. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol. 2005;96:303-305.
59. Binder L, Pieske B, Olschewski M, et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation. 2005;112:1573-1579.
60. Leibowitz D. Role of echocardiography in the diagnosis and treatment of acute pulmonary thromboembolism. J Am Soc Echocardiogr. 2001;14:921-926.
61. Pruszczyk P, Torbicki A, Kuch-Wocial A, et al. Transoesophageal echocardiography for definitive diagnosis of haemodynamically significant pulmonary embolism. Eur Heart J. 1995;16:534-538.
62. Pruszczyk P, Torbicki A, Pacho R, et al. Noninvasive diagnosis of suspected severe pulmonary embolism: transesophageal echocardiography vs. spiral CT. Chest. 1997;112:722-728.
63. Comess KA, DeRook FA, Russell ML, et al. The incidence of pulmonary embolism in unexplained sudden cardiac arrest with pulseless electrical activity. Am J Med. 2000;109:351-356.
64. Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004,126:401S- 428S.
65. Hull RD, Raskob GE, Brant RF, et al. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med. 1997;157:2562-2568.
66. Buller HR, Davidson BL, Decousus H, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003;349:1695-1702.
67. Bates SM, Greer IA, Pabinger I, et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). Chest. 2008,133:844S- 886S.
68. Dalen JE, Alpert JS, Hirsh J. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Arch Intern Med. 1997;157: 2550-2556.
69. Witty LA, Krichman A, Tapson VF. Thrombolytic therapy for venous thromboembolism. Utilization by practicing pulmonologists. Arch Intern Med. 1994;154:1601-1604.
70. Goldhaber SZ, Kessler CM, Heit J, et al. Tissue plasminogen activator and acute pulmonary embolism. J Cell Biochem. 1988;38:303-312.
71. Goldhaber SZ, Meyerovitz MF, Markis JE, et al. Thrombolytic therapy of acute pulmonary embolism: current status and future potential. J Am Coll Cardiol. 1987;10:96B-104B.
72. Dong B, Jirong Y, Liu G, et al. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev. 2006:CD004437.
73. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002;347:1143-1150.
74. Konstantinides S, Tiede N, Geibel A, et al. Comparison of alteplase versus heparin for resolution of major pulmonary embolism. Am J Cardiol. 1998; 82:966-970.
75. Sharma G, Folland E, McIntyre K: Long-term hemodynamic benefit of thrombolytic therapy in pulmonary embolic disease. J Am Coll Cardiol. 1990;15:65A.
76. Thabut G, Thabut D, Myers RP, et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol. 2002;40:1660-1667.
77. Hirsh J, Guyatt G, Albers GW, et al. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:71S-109S. (Pubitemid 351892961)
78. Greco F, Bisignani G, Serafini O, et al. Successful treatment of right heart thromboemboli with IV recombinant tissue-type plasminogen activator during continuous echocardiographic monitoring: a case series report. Chest. 1999;116:78-82.
79. Garcon P, Cohen I, Nakad C, et al. Diagnosis of proximal pulmonary embolism by transthoracic echocardiography. J Am Soc Echocardiogr. 2008; 21:1079.
80. Madan A, Schwartz C. Echocardiographic visualization of acute pulmonary embolus and thrombolysis in the ED. Am J Emerg Med. 2004;22: 294-300.
81. Vieillard-Baron A, Qanadli SD, Antakly Y, et al. Transesophageal echocardiography for the diagnosis of pulmonary embolism with acute cor pulmonale: a comparison with radiological procedures. Intensive Care Med. 1998; 24:429-433. (Pubitemid 28274153)
82. Kurkciyan I, Meron G, Sterz F, et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med. 2000;160:1529-1535.